Home » Newsletters » BioWorld Science

BioWorld Science

June 3, 2021

View Archived Issues

Novel synthetic biotic to promote mucosal healing for treatment of IBD

CIDEC gene silencing ameliorates experimental diabetic cardiomyopathy

Researchers develop new model of extracorporeal membrane oxygenation thrombosis

ADO-09 shown to be superior to insulin aspart in type 1 diabetes patients

ATTR removal observed in vitro and in vivo with NI-006

Encouraging development updates for SupraAntigen-derived liposomal AD vaccine candidates

Centivax enters strategic partnership with NMRC for phase I development of Centi-B9

First patient enrolled in phase Ib study of LB-100 for treatment of small cell lung cancer

Wave Life Sciences presents promising preclinical data for its ADAR editing program

Lophora ApS patents 5-HT2A receptor agonists

Nurix Therapeutics presents new PROTACs

Crinetics Pharmaceuticals synthesizes new melanocortin MC2 receptor antagonists

Merck & Co. identifies nicotinic alpha7 receptor PAMs

Suzhou Zelgen Biosciences synthesizes new GTPase KRAS mutant inhibitors

Phase II results presented from study comparing AZD-9567 versus prednisolone in active RA

Preclinical and early clinical characterization of VIB-7734

Epeleuton shows efficacy in preclinical models of atherosclerosis

New biomarkers identified for diagnosis of Cushing's syndrome

U.K. study identifies another danger of COVID-19: increased antibiotic resistance

Replimune provides updated clinical data for RP-1 and RP-2 programs

Mindset selects its lead next-generation psychedelic candidate, MSP-1014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....